| Tretinoin | Approved Investigational Nutraceutical | LYPD1 | 116372 |
downregulated | Tretinoin results in decreased expression of LYPD1 mRNA | 2q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LYPD1 | 116372 |
upregulated | Tretinoin results in increased expression of LYPD1 mRNA | 2q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LYPD3 | 27076 |
downregulated | Tretinoin results in decreased expression of LYPD3 mRNA | 19q13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | LYPD6 | 130574 |
upregulated | Tretinoin results in increased expression of LYPD6 mRNA | 2q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LYPD6B | 130576 |
upregulated | Tretinoin results in increased expression of LYPD6B mRNA | 2q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LYRM4 | 57128 |
upregulated | Tretinoin results in increased expression of LYRM4 mRNA | 6p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LYSMD2 | 256586 |
downregulated | Tretinoin results in decreased expression of LYSMD2 mRNA | 15q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LYST | 1130 |
upregulated | Tretinoin results in increased expression of LYST mRNA | 1q42.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LYZ | 4069 |
downregulated | Tretinoin results in decreased expression of LYZ mRNA | 12q15 | |
| Tretinoin | Approved Investigational Nutraceutical | LZIC | 84328 |
upregulated | Tretinoin results in increased expression of LZIC mRNA | 1p36.22 | |
| Tretinoin | Approved Investigational Nutraceutical | LZTS1 | 11178 |
downregulated | Tretinoin results in decreased expression of LZTS1 mRNA | 8p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAB21L1 | 4081 |
upregulated | Tretinoin results in increased expression of MAB21L1 mRNA | 13q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAB21L2 | 10586 |
downregulated | Tretinoin results in decreased expression of MAB21L2 mRNA | 4q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MACF1 | 23499 |
upregulated | Tretinoin results in increased expression of MACF1 mRNA | 1p34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MACROD1 | 28992 |
downregulated | Tretinoin results in decreased expression of MACROD1 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAD1L1 | 8379 |
downregulated | Tretinoin results in decreased expression of MAD1L1 mRNA | 7p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAD2L1 | 4085 |
downregulated | Tretinoin results in decreased expression of MAD2L1 mRNA | 4q27 | |
| Tretinoin | Approved Investigational Nutraceutical | MADD | 8567 |
upregulated | Tretinoin results in increased expression of MADD mRNA | 11p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAF | 4094 |
downregulated | Tretinoin results in decreased expression of MAF mRNA | 16q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAF | 4094 |
upregulated | Tretinoin results in increased expression of MAF mRNA | 16q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAFB | 9935 |
downregulated | Tretinoin results in decreased expression of MAFB mRNA | 20q12 | |
| Tretinoin | Approved Investigational Nutraceutical | MAFB | 9935 |
upregulated | Tretinoin results in increased expression of MAFB mRNA | 20q12 | |
| Tretinoin | Approved Investigational Nutraceutical | MAFF | 23764 |
upregulated | Tretinoin results in increased expression of MAFF mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAFG | 4097 |
upregulated | Tretinoin results in increased expression of MAFG mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAG | 4099 |
upregulated | Tretinoin results in increased expression of MAG mRNA | 19q13.1 | |